Highlights – TAVI with Sapien 3 may be better than surgery for intermediate-risk patients; Deferred stenting in STEMI patients does not improve outcomes; Usman Baber on TWILIGHT; Profile of James Blankenship; and Francesco Maisano on new mitral valve therapies
[pdfviewer width=”100%” height=”940px” beta=”true”]http://cardiovascularnews.com/wp-content/uploads/sites/14/2016/06/CNIssue41-US.pdf[/pdfviewer]
